Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.97M Sell
125,845
-14,079
-10% -$626K ﹤0.01% 1447
2026
Q1
$5.71M Buy
139,924
+12,741
+10% +$659K ﹤0.01% 1501
2025
Q4
$8.16M Buy
127,183
+6,844
+6% +$569K ﹤0.01% 1217
2025
Q3
$12.8M Sell
120,339
-83,633
-41% -$7.04M ﹤0.01% 994
2025
Q2
$13.3M Buy
203,972
+65,224
+47% +$3.35M ﹤0.01% 1218
2025
Q1
$5.33M Buy
138,748
+15,420
+13% +$665K ﹤0.01% 1541
2024
Q4
$5.09M Buy
+123,328
New +$5.43M ﹤0.01% 1601

Other funds holding LIF

UBS AM's LIF Position: Q2 2026 in Review

UBS AM reduced its Life360 (LIF) stake by 10% in Q2 2026, selling an estimated $626K and leaving 125,845 shares worth $6.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

UBS AM first reported a position in LIF in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.3M in Q2 2025. 202 funds tracked by Wall St. Rank hold LIF as of Q2 2026.

  • UBS AM held 125,845 shares of Life360 worth $6.97M as of Q2 2026.
  • UBS AM sold 14,079 Life360 shares in Q2 2026, an estimated $626K.
  • Life360 made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1447 holding.
  • UBS AM first reported a position in Life360 in Q4 2024 and has held it in 7 quarters since.
  • UBS AM's Life360 position peaked at $13.3M in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Life360 as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.